Prevention of adverse reactions in therapy with high doses of lincomycin.
D000328:Adult; D004077:Digoxin / Q000627:therapeutic use; D004417:Dyspnea / Q000139:chemically induced; D004562:Electrocardiography; D004697:Endocarditis, Bacterial / Q000188:drug therapy*; D004698:Endocarditis, Subacute Bacterial / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D008034:Lincomycin / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D009325:Nausea / Q000139:chemically induced; D018805:Sepsis / Q000188:drug therapy*; D013203:Staphylococcal Infections / Q000188:drug therapy*; D014839:Vomiting / Q000139:chemically induced
D004077:Digoxin; D008034:Lincomycin